aTyr Pharma to Present at Upcoming Investor Conferences
LIFE 10.31.2024
About Gravity Analytica
Details of the conferences appear below:
Conference:
Conference:
Conference: 7thAnnual
Conference: Piper Sandler 36thAnnual Healthcare ConferenceDate:
In addition to the presentations, company management will be available to participate in one-on-one meetings with investors who are registered attendees of the conferences. A webcast of the presentations will be available on the Investor’s section of the company’s website atwww.atyrpharma.com. Following the events, a replay of the presentations will be available on the aTyr website for at least 90 days. For more information, contactinvestorrelations@atyrpharma.com.
About aTyr
aTyr is a clinical stage biotechnology company leveraging evolutionary intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation. tRNA synthetases are ancient, essential proteins that have evolved novel domains that regulate diverse pathways extracellularly in humans. aTyr’s discovery platform is focused on unlocking hidden therapeutic intervention points by uncovering signaling pathways driven by its proprietary library of domains derived from all 20 tRNA synthetases. aTyr’s lead therapeutic candidate is efzofitimod, a first-in-class biologic immunomodulator in clinical development for the treatment of interstitial lung disease, a group of immune-mediated disorders that can cause inflammation and progressive fibrosis, or scarring, of the lungs. For more information, please visitwww.atyrpharma.com.
| Contact: |
| Director, Investor Relations and Public Affairs |
| adunston@atyrpharma.com |
Source: aTyr Pharma, Inc.